Nasdaq Evax News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq evax. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Evax Today - Breaking & Trending Today

HC Wainwright Reaffirms "Buy" Rating for Evaxion Biotech A/S (NASDAQ:EVAX)

HC Wainwright reissued their buy rating on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a report published on Wednesday, MarketBeat reports. HC Wainwright currently has a $14.00 price target on the stock. HC Wainwright also issued estimates for Evaxion Biotech A/S’s FY2024 earnings at ($0.01) EPS, FY2025 earnings at $0.13 EPS, FY2026 […] ....

Jpmorgan Chase Co , Beacon Capital Management , Elm Advisors , Susquehanna International Group , Ae Wealth Management , Evaxion Biotech , Free Report , International Group , Capital Management , Get Free Report , Evaxion Biotecha S , Nasdaq Evax , Reiterated Rating , Hc Wainwright ,

Evaxion Biotech A/S (NASDAQ:EVAX) Upgraded at LADENBURG THALM/SH SH

Evaxion Biotech A/S (NASDAQ:EVAX – Get Free Report) was upgraded by analysts at LADENBURG THALM/SH SH from a “neutral” rating to a “buy” rating in a report released on Tuesday, Briefing.com reports. The firm currently has a $8.00 target price on the stock. LADENBURG THALM/SH SH’s target price would suggest a potential upside of 143.16% […] ....

Elm Advisors , Ae Wealth Management , Jpmorgan Chase Co , Susquehanna International Group , Beacon Capital Management , Evaxion Biotech , Get Free Report , International Group , Capital Management , Evaxion Biotecha S , Nasdaq Evax , Ladenburg Thalm Sh ,

HC Wainwright Begins Coverage on Evaxion Biotech A/S (NASDAQ:EVAX)

HC Wainwright began coverage on shares of Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) in a report published on Monday, MarketBeat reports. The brokerage issued a buy rating and a $14.00 price target on the stock. HC Wainwright also issued estimates for Evaxion Biotech A/S’s FY2023 earnings at ($6.90) EPS, FY2024 earnings at ($0.10) EPS, […] ....

Jpmorgan Chase Co , Beacon Capital Management , Elm Advisors , Ae Wealth Management , Susquehanna International Group , Evaxion Biotech , Free Report , Get Free Report , International Group , Capital Management , Evaxion Biotecha S , Nasdaq Evax , Initiated Coverage , Hc Wainwright ,

Evaxion Biotech Announces Pricing of $15 Million Public

COPENHAGEN, Denmark, Feb. 01, 2024 (GLOBE NEWSWIRE) Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio company. ....

United States , New York , Hc Wainwright Co , Exchange Commission , Merck Co Inc , Securities Exchange , Global Health Innovation Fund , American Depositary Shares , Health Innovation Fund , Securities Act , Securities Exchange Act , Middle East , Annual Report , Nasdaq Evax , Evaxion Biotech , Public Offering ,

Evaxion Biotech A/S Stock Scheduled to Reverse Split on Monday, January 22nd (NASDAQ:EVAX)

Evaxion Biotech A/S (NASDAQ:EVAX – Free Report) shares are going to reverse split on the morning of Monday, January 22nd. The 1-10 reverse split was announced on Monday, January 22nd. The number of shares owned by shareholders will be adjusted after the market closes on Monday, January 22nd. Evaxion Biotech A/S Price Performance NASDAQ:EVAX opened […] ....

Ae Wealth Management , Evaxion Biotechas Company Profile , Jpmorgan Chase Co , Susquehanna International Group , Beacon Capital Management , Evaxion Biotech , Free Report , Get Free Report , International Group , Capital Management , Evaxion Biotecha S , Nasdaq Evax , Stock Split ,